GB9423868D0 - Compounds for use in medicine - Google Patents

Compounds for use in medicine

Info

Publication number
GB9423868D0
GB9423868D0 GB9423868A GB9423868A GB9423868D0 GB 9423868 D0 GB9423868 D0 GB 9423868D0 GB 9423868 A GB9423868 A GB 9423868A GB 9423868 A GB9423868 A GB 9423868A GB 9423868 D0 GB9423868 D0 GB 9423868D0
Authority
GB
United Kingdom
Prior art keywords
medicine
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB9423868A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kings College London
Wellcome Foundation Ltd
Original Assignee
Kings College London
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kings College London, Wellcome Foundation Ltd filed Critical Kings College London
Priority to GB9423868A priority Critical patent/GB9423868D0/en
Publication of GB9423868D0 publication Critical patent/GB9423868D0/en
Priority to PCT/GB1995/002745 priority patent/WO1996016645A1/fr
Priority to AU38788/95A priority patent/AU3878895A/en
Pending legal-status Critical Current

Links

GB9423868A 1994-11-25 1994-11-25 Compounds for use in medicine Pending GB9423868D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB9423868A GB9423868D0 (en) 1994-11-25 1994-11-25 Compounds for use in medicine
PCT/GB1995/002745 WO1996016645A1 (fr) 1994-11-25 1995-11-24 Utilisation de donneurs d'oxyde nitrique dans le domaine medical
AU38788/95A AU3878895A (en) 1994-11-25 1995-11-24 Use of nitric oxide donors in medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9423868A GB9423868D0 (en) 1994-11-25 1994-11-25 Compounds for use in medicine

Publications (1)

Publication Number Publication Date
GB9423868D0 true GB9423868D0 (en) 1995-01-11

Family

ID=10765012

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9423868A Pending GB9423868D0 (en) 1994-11-25 1994-11-25 Compounds for use in medicine

Country Status (3)

Country Link
AU (1) AU3878895A (fr)
GB (1) GB9423868D0 (fr)
WO (1) WO1996016645A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6911427B1 (en) 1995-09-15 2005-06-28 Duke University No-modified hemoglobins and uses therefore
US6627738B2 (en) 1995-09-15 2003-09-30 Duke University No-modified hemoglobins and uses therefor
US6916471B2 (en) 1995-09-15 2005-07-12 Duke University Red blood cells loaded with S-nitrosothiol and uses therefor
US6855691B1 (en) 1995-09-15 2005-02-15 Duke University Methods for producing and using S-nitrosohemoglobins
US6153186A (en) 1995-09-15 2000-11-28 Duke University Medical Center Red blood cells loaded with S-nitrosothiol and uses therefor
US6197745B1 (en) 1995-09-15 2001-03-06 Duke University Methods for producing nitrosated hemoglobins and therapeutic uses therefor
US5770645A (en) * 1996-08-02 1998-06-23 Duke University Medical Center Polymers for delivering nitric oxide in vivo
US6232434B1 (en) 1996-08-02 2001-05-15 Duke University Medical Center Polymers for delivering nitric oxide in vivo
US6057367A (en) * 1996-08-30 2000-05-02 Duke University Manipulating nitrosative stress to kill pathologic microbes, pathologic helminths and pathologically proliferating cells or to upregulate nitrosative stress defenses
IT1288123B1 (it) * 1996-09-04 1998-09-10 Nicox Sa Uso di nitroderivati per l'incontinenza urinaria
ES2147162B1 (es) 1999-01-27 2001-03-16 Lacer Sa "s-nitrosotioles como agentes para el tratamiento de disfunciones circulatorias".
US6589759B1 (en) 1999-03-30 2003-07-08 Trustees Of Boston University Compositions and methods for producing platelets and/or proplatelets from megakaryocytes
CA2410632A1 (fr) 2000-06-22 2001-12-27 David S. Garvey Taxanes nitroses et nitrosyles, compositions et procedes d'utilisation
US6359182B1 (en) * 2000-10-26 2002-03-19 Duke University C-nitroso compounds and use thereof
US7049308B2 (en) 2000-10-26 2006-05-23 Duke University C-nitroso compounds and use thereof
WO2004024186A2 (fr) * 2002-09-11 2004-03-25 Nitromed, Inc. Inhibition de maladies et de troubles induits par la cyclooxygenase-3
EP4240351A1 (fr) 2020-11-20 2023-09-13 Institute of Life Sciences (ILS) Composition pour augmentation de la génération d'oxyde nitrique intracellulaire

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5025001A (en) * 1988-06-15 1991-06-18 Brigham And Women's Hospital S-nitroso derivatives of ACE inhibitors and the use thereof
US5385937A (en) * 1991-04-10 1995-01-31 Brigham & Women's Hospital Nitrosation of homocysteine as a method for treating homocysteinemia
US5185376A (en) * 1991-09-24 1993-02-09 The United States Of America As Represented By The Department Of Health And Human Services Therapeutic inhibition of platelet aggregation by nucleophile-nitric oxide complexes and derivatives thereof
EP1023905B1 (fr) * 1991-11-14 2005-01-26 The Brigham And Women's Hospital, Inc. Composition pharmaceutique contenant S-nitroso-immunoglobulines et son utilisation
DE4222933A1 (de) * 1992-07-11 1994-01-13 Cassella Ag Heterocyclische N-Nitrosimine
US5650447A (en) * 1992-08-24 1997-07-22 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Nitric oxide-releasing polymers to treat restenosis and related disorders
US5405919A (en) * 1992-08-24 1995-04-11 The United States Of America As Represented By The Secretary Of Health And Human Services Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions and methods of treating biological disorders
WO1994016729A1 (fr) * 1993-01-28 1994-08-04 Neorx Corporation Modulation ciblee de synthase d'oxyde nitrique ou de voie d'oxyde nitrique
EP0702518B1 (fr) * 1993-06-11 2003-04-02 The Board Of Trustees Of The Leland Stanford Junior University Traitement des maladies vasculaires degeneratives par modulation de l'activite ou de la production d'oxyde nitrique endogene
CA2106105C (fr) * 1993-09-14 2008-03-18 Larry K. Keefer Compositions d'addition oxyde nitrique-agent polymerique liees par des polymeres, compositions pharmaceutiques incorporant ces produits et methodes pour le traitement de desordresbiologiques a l'aide de ceux-ci
JPH09504274A (ja) * 1993-09-17 1997-04-28 ブリガム アンド ウィメンズ ホスピタル 人工表面および血管面の血栓を予防する酸化窒素付加物の利用
ATE192922T1 (de) * 1993-11-02 2000-06-15 Us Health Verwendung von stickstoffoxid freisetzenden verbindungen zur herstellung eines arzneimittels zum schutz gegen die ischämischen reperfusionsschäden
US5482925A (en) * 1994-03-17 1996-01-09 Comedicus Incorporated Complexes of nitric oxide with cardiovascular amines as dual acting cardiovascular agents
DE4410997A1 (de) * 1994-03-30 1995-10-26 Isis Pharma Gmbh Pharmazeutische Zubereitungen und Arzneistoffe zur Prävention und Behandlung endothelialer Dysfunktionen
DE4420523A1 (de) * 1994-06-13 1995-12-14 Cassella Ag Verwendung von NO-freisetzenden Verbindungen zur Behandlung und Vorbeugung von systemischen Entzündungssyndromen

Also Published As

Publication number Publication date
AU3878895A (en) 1996-06-19
WO1996016645A1 (fr) 1996-06-06

Similar Documents

Publication Publication Date Title
EG24222A (en) Spiro-azabicyclic compounds useful in therapy
GB9402807D0 (en) Pharmaceutical compounds
EP0785806A4 (fr) Seringue a usage unique
GB9410387D0 (en) Pharmaceutical compounds
GB9423868D0 (en) Compounds for use in medicine
GB2286394B (en) Pharmaceutical compounds
GB9418326D0 (en) Pharmaceutical compounds
GB9416467D0 (en) Compounds for use in medicine
GB9424694D0 (en) Compounds for use in medicine
GB9414157D0 (en) Medical use
GB9417102D0 (en) Pharmaceutical compounds
GB9625449D0 (en) Compounds for use in medicine
GB9402805D0 (en) Pharmaceutical compounds
GB9501142D0 (en) Compounds for use in medicine
GB9503567D0 (en) Compounds for use in medicine
GB9514685D0 (en) Sterilisable set for self-injecting drugs
GB9317145D0 (en) Compounds for use in medicine
GB9202692D0 (en) Compounds for use in medicine
GB9504627D0 (en) Compounds for use in therapy
GB9417084D0 (en) Compounds useful in therapy
GB9411293D0 (en) Compounds useful in therapy
GB9411244D0 (en) Compounds useful in therapy
GB9422497D0 (en) Compounds useful in therapy
GB9417501D0 (en) Compounds useful in therapy
GB9419434D0 (en) Pharmaceutical use